Pharmaceutical Accountability Foundation

News from and about the Pharmaceutical Accountability Foundation

Recent News

New in the Journal of Health and Human Rights: “Deepening Accountability: The Fair Pharma Scorecard and Access to Medicines in a Fragmented Global Health...

On the occasion of Human Rights Day, the Pharmaceutical Accountability Foundation is pleased to announce a new publication in the Journal of Health and Human...

Amsterdam Court Gives no Substantive Ruling in Pharmaceutical Accountability Foundation-AbbVie Excessive Pricing Case on Humira

AMSTERDAM, 9 July 2025: The Amsterdam District Court declared the Pharmaceutical Accountability Foundation (PAF) inadmissible in its court case against AbbVie, and has thus not...

The Excessive Pricing Case Against AbbVie verdict will become available 9 July

Update following 9 May 2025 Hearing: Amsterdam District Court to decide on the merits of the case on 9 July 2025. AMSTERDAM, THE NETHERLANDS: In February...

PAF – AbbVie Humira case comes to court May 9, 2025

Friday, May 9 (09:30-12:30), Farma ter Verantwoording and AbbVie will meet at the Amsterdam District Court, Parnassusweg 280, 1076 AV Amsterdam (near Amsterdam Zuid train...

€17m fine imposed to pharma pirate Leadiant upheld on appeal

AMSTERDAM, THE NETHERLANDS: The District Court of Rotterdam has rejected the appeal of pharmaceutical company Leadiant against the 2021 decision of the Netherlands Competition Authority...

The Lancet on the PAF AbbVie case: AbbVie to face potentially groundbreaking case over Humira

The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to the...

Subscribe to our newsletter

Never miss an update from the Pharmaceutical Accountability Foundation!



PAF in the News

  • 22 Februari, de Volkskrant

Featured, 24 February, The British Medical Journal: Sharifah Sekalala, Katrina Perehudoff et al. An intersectional human rights approach toprioritising access to COVID-19 vaccines.

 

For Journalists

Interested in writing about our work? Please get in touch at press@farmaterverantwoording.nl

News by topic